Market capitalization of Iovance Biotherapeutics (IOVA)

Market cap: NZ$4.68 Billion

As of October 2024 Iovance Biotherapeutics has a market cap of NZ$4.68 Billion. This makes Iovance Biotherapeutics the world's 3698th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

End of year Market Cap

End of Day market cap according to different sources

On Oct 16th, 2024 the market cap of Iovance Biotherapeutics was reported to be:

NZ$4.68 Billion

by Yahoo Finance

NZ$4.68 Billion

by CompaniesMarketCap

NZ$4.68 Billion

by Nasdaq

Market capitalization for similar companies or competitors

Name	Marketcap	Market cap differencediff.	Country
NRC Health NRC	NZ$0.76 B	-83.67%	🇺🇸 USA
Nymox Pharmaceutical NYMX	NZ$30.04 M	-99.36%	Bahamas